We use cookies for analytics and ads to improve your experience. You can accept or decline. See our Privacy Policy.
Unlisted shares are illiquid and carry higher risk than listed securities. Prices are indicative, not live. Read the risk disclosure.

Valuation
Financials (FY2024)
Source: CRISILInvestment Thesis
Farmax India Limited is a small, South India-focused FMCG manufacturer with a legacy presence in rural personal care markets. The penny stock price reflects current business challenges. Unless there is a significant strategic intervention — either organically or through an acquisition — the company faces an uphill battle against well-resourced national competitors.
Pros
Cons
Business Segments
Hair Care
Hair oils, shampoos, hair dyes, and hair conditioning products targeting mass-market rural consumers
Skin Care
Cold creams, fairness creams, talcum powder, and body lotions for value-conscious consumers
Oral Care
Toothpowder and toothpaste products targeting rural markets where toothpowder still has strong penetration
Household Products
Washing powder, dish wash bars, and other household cleaning products
Revenue Model
Farmax India generates revenue through manufacture and sale of branded FMCG products across personal care and household categories. Products are distributed through a network of distributors, wholesalers, and retail outlets primarily in Andhra Pradesh and Telangana. Revenue is volume-driven with thin unit margins, relying on high throughput in rural and semi-urban markets.
Detailed Analysis
Growth Plans
Rural consumption revival driven by good monsoon seasons and farm income growth
Potential brand rejuvenation or product portfolio revamp under new strategy
Possible acquisition by a larger FMCG player seeking South India distribution access
Growth in local/regional brands as consumers increasingly prefer vernacular products
Industry Tailwinds
Recent Developments
With a share price at Re 1, the company is likely undergoing operational consolidation or facing revenue pressure from intense competition from larger FMCG players.
2023Rising input costs for petrochemical-derived raw materials and packaging impacted margins across small FMCG manufacturers including Farmax India.
2022Comparable Companies
HINDUNILVR · ~Rs 5,50,000 Cr
EMAMILTD · ~Rs 16,000 Cr
Frequently Asked Questions
About Farmax India
Farmax India Limited is a Hyderabad-based FMCG company incorporated in 1995 (CIN: L27109TG1995PLC022190) that manufactures and markets personal care and household consumer products. The company operates in the mass-market consumer segment targeting rural and semi-urban Indian consumers, particularly in South India. Farmax's product portfolio historically included personal care products such as fairness creams, hair care products, and household consumer goods sold under its own brands. The company pursued a rural FMCG distribution strategy, reaching consumers in Tier III and IV markets through a wide dealer network. However, Farmax India has reported declining revenues, with recent figures of approximately Rs 4.38 crore — a sharp reduction from historical levels. This revenue decline suggests significant business contraction, potentially due to competition from large FMCG players like HUL, Dabur, and Marico that have aggressively expanded into rural markets. For investors, Farmax represents a declining FMCG company struggling against formidable competition. The very small current revenue suggests the business may be in deep contraction. Detailed financial analysis and operational assessment are essential before any investment consideration. Shares are available through platforms like UnlistedZone, but the investment case requires careful evaluation.
Key Milestones
1995: Farmax India Limited incorporated in Telangana (then Andhra Pradesh) under CIN L27109TG1995PLC022190
Common questions about unlisted shares
You buy from and sell to the wisefolio desk — shares route through the desk's demat, money-in before shares-out.
You enquire
· Takes 2 minutesTell us the company and quantity you want. Share your demat details so we can settle directly into your account.
We source & quote
· Typically within 1 business dayOur desk sources the shares and comes back with a firm price and an allocation for the quantity available.
You accept the allocation
· Quote valid for 3 daysReview the price, quantity and total. Accept to lock the allocation. The quote is valid for a short window before it needs re-pricing.
You transfer the funds
· Pay within 2 days of acceptingPay by direct bank transfer to the desk's published account — never to a personal account. We confirm receipt and begin the transfer.
Shares reach your demat
· Usually credited within 2–3 business daysOnce payment is verified, the shares are transferred from the desk's demat into yours, and you receive a transfer confirmation.
A principal desk for unlisted & pre-IPO shares — you transact with us, not a stranger.
You enquire
Takes 2 minutes
We source & quote
Typically within 1 business day
You accept the allocation
Quote valid for 3 days
You transfer the funds
Pay within 2 days of accepting
Shares reach your demat
Usually credited within 2–3 business days
Unlisted shares are illiquid and carry higher risk. Pricing is indicative, not live, and these are private off-market transactions with no exchange settlement guarantee. Read the full risk disclosure.
Be the first to discuss Farmax India — share your research, ask questions, or compare notes with other investors.
Rural consumption revival driven by good monsoon seasons and farm income growth
Potential brand rejuvenation or product portfolio revamp under new strategy
Possible acquisition by a larger FMCG player seeking South India distribution access
Growth in local/regional brands as consumers increasingly prefer vernacular products
Industry Headwinds
Ongoing erosion of market share to national brands with deeper distribution and higher ad spend
Financial constraints limiting ability to invest in product innovation or marketing
Potential delisting or dissolution if business recovery does not materialise
Changing consumer preferences towards premium and organised FMCG offerings
Revenue declining to Rs 4.38 Cr — deep business contraction
Source: Company Financial Filings
High competition risk from large FMCG companies
Source: AlphaHub Research
The penny stock price level at Re 1 suggests potential accumulated losses or balance sheet stress that may require capital infusion or restructuring.
The mass-market FMCG space is dominated by HUL, P&G, Dabur, Marico, and Emami — all of which have significantly greater distribution, R&D, and marketing capabilities.
Heavy reliance on Andhra Pradesh and Telangana markets makes revenue vulnerable to regional economic downturns, floods, or unfavorable agricultural seasons.
FMCG personal care products rely on petrochemical derivatives (surfactants, mineral oil) and agricultural commodities, both of which experience price volatility.
Limited marketing spend means brand awareness is weak compared to national brands, making customer retention challenging especially as organised retail penetrates rural markets.
Late 1990s: Launched initial range of hair care and personal care products targeting South Indian rural markets
2000s: Expanded distribution network across Andhra Pradesh covering rural mandals and panchayat-level retailers
2010s: Introduction of toothpowder, oral hygiene, and household cleaning products to broaden portfolio
Post-2014: Operations continued following the bifurcation of Andhra Pradesh into AP and Telangana
2020s: Business scale appears reduced based on penny stock price levels, suggesting possible operational challenges